Clearing Regulatory Hurdles

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-02-2003
Volume 27
Issue 11

The authors propose several models for independent evaluation of new excipients.

External Link - article-75179.pdf

Articles in this issue
FDA Will Drive Changes for Contract Business
In the Spotlight--December
Novemember 2003
FDA Seeks Risk-Based Inspection Program
Routine Sample Size for a Retest Procedure
November 2003
Aseptic Processing Guidelines and Innovative Engineering Boost Appeal of Barrier Isolators
Clearing Regulatory Hurdles
Improving Protein Capture for Transgenic Drug Processing
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Paige, Sonrai Form Partnership to Harness AI for Precision Medicine R&D

Patrick Lavery
April 21st 2025
Article
Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Bavarian Nordic Chikungunya Vaccine Recommended by CDC's ACIP

Patrick Lavery
April 18th 2025
Article

The recombinant vaccine, under the brand name Vimkunya, is recommended for persons age 12 and older who are traveling to a country or territory where there is a chikungunya outbreak.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

New CDMO Meribel Pharma Solutions Launches with 13 Sites in Europe

Patrick Lavery
April 16th 2025
Article

The new United Kingdom-based firm has sites located in France, Spain, and Sweden, thanks to an acquisition of Synerlab Group and several Recipharm facilities in 2024.

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Alicia Bigica
April 16th 2025
Article

On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.